09/25/2024 | Press release | Distributed by Public on 09/25/2024 06:19
by John Conrad| Sep 25, 2024| NewsBrief
PCI Pharma Services is set to significantly expand its presence in Rockford, Illinois, as part of a broader $365 million investment across its U.S. and European operations. The contract development and manufacturing organization (CDMO) announced on Tuesday, September 24, 2024, that Rockford will be the centerpiece of its ambitious growth strategy.
The Illinois expansion includes:
PCI plans to bring the Rockford expansion online in two phases, with initial operations slated to begin in the third quarter of 2025. This substantial investment in Illinois underscores the state's growing importance in the pharmaceutical manufacturing landscape.
The company cited recent new business as the driving force behind this expansion, positioning Rockford to capitalize on growth opportunities in the injectable drug delivery market. PCI's focus on advanced drug-device combination products aligns with industry trends toward more sophisticated and patient-friendly delivery systems.
While the Illinois project takes center stage, PCI is also expanding its footprint internationally:
These global investments complement the Rockford expansion, strengthening PCI's position as a leading CDMO with a significant presence in the American Midwest.
The Rockford project follows a $50 million expansion at the same site announced last spring, highlighting PCI's continued commitment to growing its Illinois operations. As the pharmaceutical industry evolves, Rockford is poised to become a key hub for advanced drug delivery manufacturing, bringing potential economic benefits and job opportunities to the region.